Glucagon-like peptide-1 (GLP-1) is a peptide hormone with anti-inflammatory effects which was first found to regulate insulin secretion from pancreatic β-cells, and agonists of GLP-1 receptor are widely used for the treatment of type 2 diabetes mellitus all over the world1. This evidence concerns the gene GCG and type 2 diabetes mellitus.